MENU

CLOSE

Bold solutions with the

Capacity
toCure

At Poseida Therapeutics, we are boldly developing new solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. We have designed our genetic engineering technologies to represent the future of innovation in cell and gene therapies, giving new hope to patients.

At Poseida Therapeutics, we are boldly developing new solutions to redefine treatment paradigms for life-threatening cancers and genetic diseases. We have designed our genetic engineering technologies to represent the future of innovation in cell and gene therapies, giving new hope to patients.

A close image of a gloved hand holding an orange cap to a cell culture flask. The flask stands upright with a pipette poised above the opening.
A close image of a gloved hand holding an orange cap to a cell culture flask. The flask stands upright with a pipette poised above the opening.

TECHNOLOGY

A Suite of Differentiated Genetic Engineering Platforms

Our non-viral piggyBac® DNA Delivery System inserts large genetic payloads into the genome. Our Cas-CLOVER™ Site-Specific Gene Editing System can be leveraged to make accurate site-specific deletions, insertions, and knock-ins in multiple cell types.

DISCOVER OUR TECHNOLOGY
A scientist wearing glasses, a white lab coat, and black lab gloves stands beside a supply cabinet and holds up a tube to view its contents.
A scientist wearing glasses, a white lab coat, and black lab gloves stands beside a supply cabinet and holds up a tube to view its contents.

PIPELINE

Cell Type Matters

Our gene editing technologies and delivery platforms allow us to target many different cell types to treat cancer and genetic diseases. By focusing on specific cell populations, we can potentially advance fully allogeneic CAR-T therapies with an early memory phenotype for patients fighting cancer or develop functional cures for rare genetic diseases.

View our pipeline
A Poseida employee stands at the front of a full conference room presenting slides displayed on a screen. Several employees sitting around the conference table look at the slides.
A Poseida employee stands at the front of a full conference room presenting slides displayed on a screen. Several employees sitting around the conference table look at the slides.

ABOUT US

Poseida Stands Apart

Our leadership team combines long-standing scientific expertise with the strategic insight needed to advance the company forward and deliver novel therapeutics for patients.

Meet the Team

Transformative Treatments

“We are developing a new class of cell

  and gene therapies to revolutionize the

  treatment of cancers and genetic diseases.”

“We are developing a new class

  of cell and gene therapies to

  revolutionize the treatment of

  cancers and genetic diseases.”

 ERIC M. OSTERTAG, M.D., Ph.D.

  Founder

Latest News and Updates

Advancing best-in-class allogeneic CAR-T therapies

Immuno-Oncology Insights

 | 

April 17, 2023
A headshot of Brent Warner in a convention center hallway.
A headshot of Brent Warner in a convention center hallway.

Developing Nonviral Gene Therapy for Hemophilia A

CGTLive

 | 

January 9, 2023

Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes: Genetic Medicines Day

Press Release

 | 

May 23, 2023

Poseida Therapeutics to Present at 31st Congress of the International Society on Thrombosis and Haemostasis

Press Release

 | 

May 22, 2023

Poseida Therapeutics Presents Encouraging Preclinical Data Across its Gene Therapy Programs at the American Society for Gene and Cell Therapy 2023 Annual Meeting

Press Release

 | 

May 18, 2023
View all news